379 related articles for article (PubMed ID: 26391046)
1. Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.
Strupp BJ; Powers BE; Velazquez R; Ash JA; Kelley CM; Alldred MJ; Strawderman M; Caudill MA; Mufson EJ; Ginsberg SD
Curr Alzheimer Res; 2016; 13(1):97-106. PubMed ID: 26391046
[TBL] [Abstract][Full Text] [Related]
2. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
[TBL] [Abstract][Full Text] [Related]
3. Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.
Kelley CM; Ash JA; Powers BE; Velazquez R; Alldred MJ; Ikonomovic MD; Ginsberg SD; Strupp BJ; Mufson EJ
Curr Alzheimer Res; 2016; 13(1):84-96. PubMed ID: 26391045
[TBL] [Abstract][Full Text] [Related]
4. Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.
Ash JA; Velazquez R; Kelley CM; Powers BE; Ginsberg SD; Mufson EJ; Strupp BJ
Neurobiol Dis; 2014 Oct; 70():32-42. PubMed ID: 24932939
[TBL] [Abstract][Full Text] [Related]
5. Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring.
Powers BE; Kelley CM; Velazquez R; Ash JA; Strawderman MS; Alldred MJ; Ginsberg SD; Mufson EJ; Strupp BJ
Neuroscience; 2017 Jan; 340():501-514. PubMed ID: 27840230
[TBL] [Abstract][Full Text] [Related]
6. Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.
Kelley CM; Ginsberg SD; Alldred MJ; Strupp BJ; Mufson EJ
Dev Neurobiol; 2019 Jul; 79(7):664-683. PubMed ID: 31120189
[TBL] [Abstract][Full Text] [Related]
7. CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation.
Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
Hippocampus; 2018 Apr; 28(4):251-268. PubMed ID: 29394516
[TBL] [Abstract][Full Text] [Related]
8. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
[TBL] [Abstract][Full Text] [Related]
9. Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome.
Moon J; Chen M; Gandhy SU; Strawderman M; Levitsky DA; Maclean KN; Strupp BJ
Behav Neurosci; 2010 Jun; 124(3):346-61. PubMed ID: 20528079
[TBL] [Abstract][Full Text] [Related]
10. Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.
Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
J Comp Neurol; 2014 Apr; 522(6):1390-410. PubMed ID: 24178831
[TBL] [Abstract][Full Text] [Related]
11. Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation.
Alldred MJ; Pidikiti H; Heguy A; Roussos P; Ginsberg SD
FASEB J; 2023 Jun; 37(6):e22944. PubMed ID: 37191946
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Alldred MJ; Chao HM; Lee SH; Beilin J; Powers BE; Petkova E; Strupp BJ; Ginsberg SD
FASEB J; 2019 Sep; 33(9):9871-9884. PubMed ID: 31180719
[TBL] [Abstract][Full Text] [Related]
13. Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.
Alldred MJ; Penikalapati SC; Lee SH; Heguy A; Roussos P; Ginsberg SD
Mol Neurobiol; 2021 Oct; 58(10):5141-5162. PubMed ID: 34263425
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
[TBL] [Abstract][Full Text] [Related]
15. Maternal Choline Supplementation as a Potential Therapy for Down Syndrome: Assessment of Effects Throughout the Lifespan.
Powers BE; Velazquez R; Strawderman MS; Ginsberg SD; Mufson EJ; Strupp BJ
Front Aging Neurosci; 2021; 13():723046. PubMed ID: 34690739
[TBL] [Abstract][Full Text] [Related]
16. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
[TBL] [Abstract][Full Text] [Related]
17. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the cholinergic basal forebrain in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Kelley CM; Powers BE; Velazquez R; Ash JA; Ginsberg SD; Strupp BJ; Mufson EJ
Brain Pathol; 2014 Jan; 24(1):33-44. PubMed ID: 23802663
[TBL] [Abstract][Full Text] [Related]
19. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
20. Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).
Alldred MJ; Lee SH; Petkova E; Ginsberg SD
Brain Struct Funct; 2015 Sep; 220(5):2983-96. PubMed ID: 25031177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
